Pharmaceutical Executive-10-25-2006

Pharmaceutical Executive

October 25, 2006

Merck's Januvia has a head start, but Novartis isn't sitting idle.

Pharmaceutical Executive

October 25, 2006

Emerging countries are expected to drive pharma's earnings next year.

Pharmaceutical Executive

October 25, 2006

After winning a bidding war for Pliva, the well-positioned generic maker is giving pharma reason to worry.